SPARTEINE METABOLISM IN CANADIAN CAUCASIANS

被引：95

作者：

VINKS, A ^{[1
]}

INABA, T ^{[1
]}

OTTON, SV ^{[1
]}

KALOW, W ^{[1
]}

机构：

[1] UNIV TORONTO, FAC MED, DEPT PHARMACOL, TORONTO M5S 1A1, ONTARIO, CANADA

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1982年 / 31卷 / 01期

关键词：

D O I：

10.1038/clpt.1982.4

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：23 / 29

页数：7

共 25 条

[1] PHARMACOGENETIC COVARIATION OF DEFECTIVE N-OXIDATION OF SPARTEINE AND 4-HYDROXYLATION OF DEBRISOQUINE
BERTILSSON, L
DENGLER, HJ
EICHELBAUM, M
SCHULZ, HU
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 17 (02) : 153 - 155
[2] NORTRIPTYLINE AND ANTIPYRINE CLEARANCE IN RELATION TO DEBRISOQUINE HYDROXYLATION IN MAN
BERTILSSON, L
EICHELBAUM, M
MELLSTROM, B
SAWE, J
SCHULZ, HU
SJOQVIST, F
[J]. LIFE SCIENCES, 1980, 27 (18) : 1673 - 1677
[3] EVIDENCE FOR AN ENZYMATIC DEFECT IN THE 4-HYDROXYLATION OF DEBRISOQUINE BY HUMAN-LIVER
DAVIES, DS
KAHN, GC
MURRAY, S
BRODIE, MJ
BOOBIS, AR
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 11 (01) : 89 - 91
[4] DENGLER HJ, 1977, ARZNEIMITTEL-FORSCH, V27-2, P1836
[5] INFLUENCE OF THE DEFECTIVE METABOLISM OF SPARTEINE ON ITS PHARMACOKINETICS
EICHELBAUM, M
SPANNBRUCKER, N
DENGLER, HJ
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 16 (03) : 189 - 194
[6] DEFECTIVE N-OXIDATION OF SPARTEINE IN MAN - NEW PHARMACOGENETIC DEFECT
EICHELBAUM, M
SPANNBRUCKER, N
STEINCKE, B
DENGLER, HJ
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 16 (03) : 183 - 187
[7] EICHELBAUM M, 1978, BIOL OXIDATION NITRO, P113
[8] Eichelbaum M, 1975, 6TH INT C PHARM HELS, P1071
[9] A FAMILY AND POPULATION STUDY OF THE GENETIC-POLYMORPHISM OF DEBRISOQUINE OXIDATION IN A WHITE BRITISH-POPULATION
EVANS, DAP
MAHGOUB, A
SLOAN, TP
IDLE, JR
SMITH, RL
[J]. JOURNAL OF MEDICAL GENETICS, 1980, 17 (02) : 102 - 105
[10] POLYMORPHISMS OF OXIDATION AT CARBON CENTERS OF DRUGS AND THEIR CLINICAL SIGNIFICANCE
IDLE, JR
SMITH, RL
[J]. DRUG METABOLISM REVIEWS, 1979, 9 (02) : 301 - 317

← 1 2 3 →